authors
- Sklepinski, Stacey M
- Borah, Bijan J
- Maron, Bradley A
- Mickelson, Mindy M
- McCoy, Rozalina G
- Deng, Yihong
- Swarna, Kavya Sindu
- Herrin, Jeph
- Polley, Eric C
- Neumiller, Joshua J
- Galindo, Rodolfo J
- Umpierrez, Guillermo E
- Joseph S. Ross, MD, MHS
Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- September 20, 2025
published in
has subject area
- Adult
- Aged
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2
- Exenatide
- Female
- Glucagon-Like Peptide 1
- Glucagon-Like Peptide-1 Receptor Agonists
- Glucagon-Like Peptides
- Heart Disease Risk Factors
- Humans
- Hypoglycemic Agents
- Immunoglobulin Fc Fragments
- Liraglutide
- Male
- Middle Aged
- Recombinant Fusion Proteins
- Treatment Outcome